Subject
Neurology (clinical),Neurology,General Medicine
Reference21 articles.
1. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial;Marson;Lancet,2021
2. Childhood Absence Epilepsy Study Group. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy;Glauser;N Engl J Med,2010
3. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs;Meador;N Engl J Med,2009
4. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism;Christensen;JAMA,2013
5. https://www.ema.europa.eu/en/documents/referral/valproate-article-31-referral-new-measures-avoid-valproate-exposure-pregnancy-endorsed_en-0.pdf.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献